<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-92075</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Descriptive analysis of diseases associated with Streptococcus bovis bacteremia</dc:title>
<dc:description xml:lang="en">Background and objective: It is well-known the relationship between Streptococcus bovis (S. bovis) bacteremia and colon cancer, liver cirrhosis and others neoplasms. However, a study protocol to rule out these underlying diseases has not been carried out yet. Our objective was to describe S. bovis bacteremia and associated diseases.  Patients and method: Multicenter, retrospective cohort study. S. bovis bacteremias episodes between 2001 and 2009 were included. Mean variables: colon neoplasm, non-colonic neoplasm or liver cirrhosis. Epidemiologist aspects, bacteremia related variables, personal and familiar history and clinical and analytical data were collected.Results: Ninety three patients were included. One out of four individuals had a colon neoplasm. Fifty seven per cent were concomitant cases with bacteremia and six cases were diagnosed after bacteremia (time bacteremia-diagnosis of neoplasm [months], median [Q1-Q3], 2.6 [1-11]). Fourteen (15%) patients were diagnosed with any non-colonic neoplasm (mainly biliary and pancreatic [6 cases] or esophagus-gastric [3 cases]). There were three patients (21%) with concomitant bacteremia non-colonic neoplasm and two after it (1.2 and 10.4 months). Twenty-one (23%) patients suffered from liver cirrhosis. Conclusions: Patients with S. bovis bacteremia must undergo a study designed to rule out underlying diseases. We suggest that this study should include: a colonic evaluation, ideally by colonoscopy, a liver evaluation by serum chemistry, an abdominal ultrasound scan or a method of liver fibrosis assessment, a gastroscopy and an evaluation of biliary and pancreatic areas by magnetic resonance imaging</dc:description>
<dc:creator>Mateos-Gómez, Ana</dc:creator>
<dc:creator>Georgieva, Radka Ivanova</dc:creator>
<dc:creator>Huaroc Roca, Edward</dc:creator>
<dc:creator>Pérez Rivera, Ana Ángeles</dc:creator>
<dc:creator>Jarilla Fernández, Francisco</dc:creator>
<dc:creator>García López, María Victoria</dc:creator>
<dc:creator>Corzo Delgado, Juan Enrique</dc:creator>
<dc:creator>Guerrero Sánchez, Francisca</dc:creator>
<dc:creator>Alarcón, Arístides de</dc:creator>
<dc:creator>González-Nieto, José Antonio</dc:creator>
<dc:creator>Lepe, José Antonio</dc:creator>
<dc:creator>Vergara-López, Salvador</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento y objetivo: Aunque se conoce la relación entre la bacteriemia por Streptococcus bovis (S. bovis) y el cáncer de colon, cirrosis hepática u otras neoplasias, no se ha establecido un protocolo de estudio para descartar estas enfermedades subyacentes a la bacteriemia. Nuestro objetivo fue describir la bacteriemia por S. bovis y las enfermedades asociadas.Pacientes y método: Estudio multicéntrico, retrospectivo de cohortes. Se incluyeron las bacteriemias por S. bovis entre 2001 y 2009. Las variables principales fueron: neoplasia colónica, neoplasias en otras localizaciones o cirrosis hepática. Se recogieron variables epidemiológicas, relacionadas con la bacteriemia, antecedentes personales, familiares, datos clínicos y analíticos. Resultados: Se incluyeron 93 pacientes. Un 25% de los individuos tuvo neoplasia de colon. Un 57% de ellos fueron casos concomitantes con la bacteriemia y 6 fueron diagnósticos posteriores a ella (mediana [Q1-Q3] de tiempo bacteriemia-diagnóstico neoplasia de 2,6 meses [1-11]), con un máximo de 15,4 meses. Catorce (15%) pacientes padecían alguna neoplasia no colónica (mayoritariamente biliopancreática [6 casos] y esofagogástrica [3 casos]). Hubo 3 (21%) casos concomitantes con la bacteriemia y 2 posteriores a ella (a 1,2 y 10,4 meses). Veintiún (23%) enfermos tenían cirrosis hepática.Conclusiones: A los pacientes con bacteriemia por S. bovis es necesario realizarles un estudio encaminado a descartar enfermedades subyacentes. Sugerimos que se incluyan, al menos: una prueba de imagen colónica, preferentemente colonoscopia; un estudio hepático mediante analítica, ecografía abdominal o un método de medición de fibrosis hepática; una endoscopia digestiva alta; y una prueba de imagen del área biliopancreática como la colangiorresonancia magnética</dc:description>
<dc:source>Med. clín (Ed. impr.);137(12): 527-532, nov. 2011.</dc:source>
<dc:identifier>ibc-92075</dc:identifier>
<dc:title xml:lang="es">Análisis descriptivo de las enfermedades asociadas a bacteriemia por Streptococcus bovis</dc:title>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d3142^s22012</dc:subject>
<dc:subject>^d29807^s22052</dc:subject>
<dc:subject>^d38794^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30241^s22012</dc:subject>
<dc:subject>^d13677^s22012</dc:subject>
<dc:subject>^d8276^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201111</dc:date>
</metadata>
</record>
</ibecs-document>
